The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Open accessAbstract
Peptide therapeutics have played a notable role in medical practice since the advent of insulin therapy in the 1920s. Over 60 peptide drugs are approved in the United States and other major markets, and peptides continue to enter clinical development at a steady pace. Peptide drug discovery has diversified beyond its traditional focus on endogenous human peptides to include a broader range of structures identified from other natural sources or through medicinal chemistry efforts. We maintain a comprehensive dataset on peptides that have entered human clinical studies that includes over 150 peptides in active development today. Here we provide an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Peptides (2–50 amino acids) and proteins (more than 50 amino acids) have better selectivity for human specific targets. The larger molecular size and diverse quaternary structure enhance their interaction with specific protein pockets, making peptides and protein drugs have better biological activity and lower toxicity than small molecules.294,295”
From Smart nanoparticles for cancer therapy (2023) · cites this paper as [294]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Müller, A., Schäberle, T. F., Hughes, D. E., Epstein, S. S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Camacho, P. M., Petak, S. M., Binkley, N., Clarke, B. L., Harris, S. T., Hurley, D. L., Kleerekoper, M., Lewiecki, E. M., Miller, P. D., Narula, H. S., et al. (2016) · Endocrine Practice · doi:10.4158/ep161435.esgl · Cited by 1,140
Stupp, R., Hegi, M. E., Gorlia, T., Erridge, S. C., Perry, J., Hong, Y.-K., Aldape, K. D., Lhermitte, B., Pietsch, T., Grujicic, D., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70379-1 · Cited by 1,052
Advances in Fmoc solid‐phase peptide synthesis
Behrendt, R., White, P., & Offer, J. (2016) · Journal of Peptide Science · doi:10.1002/psc.2836 · Cited by 767
(1922) · PubMed · Cited by 753
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
Finan, B., Ma, T., Ottaway, N., Müller, T. D., Habegger, K. M., Heppner, K. M., Kirchner, H., Holland, J., Hembree, J., Raver, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007218 · Cited by 696
Chang, Y. S., Graves, B. J., Guerlavais, V., Tovar, C., Packman, K. E., To, K.-H., Olson, K. A., Kesavan, K. P., Gangurde, P., Mukherjee, A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303002110 · Cited by 681
Strategic Approaches to Optimizing Peptide ADME Properties
Di, L. (2015) · The AAPS Journal · doi:10.1208/s12248-014-9687-3 · Cited by 669
Large-scale manufacture of peptide therapeutics by chemical synthesis
Bray, B. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1133 · Cited by 601
Asprosin, a Fasting-Induced Glucogenic Protein Hormone
Romere, C., Duerrschmid, C., Bournat, J., Constable, P., Jain, M., Xia, F., Saha, P. K., Del Solar, M., Zhu, B., York, B., et al. (2016) · Cell · doi:10.1016/j.cell.2016.02.063 · Cited by 591
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 501–600 of 1,001
Ma, B., Fuhrmann, J., Henriksen, H. C., Khojasteh, S. C., Li, W., Liu, J., Plise, E. G., Yu, Q., & Cheruzel, L. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02276 · Cited by 30
Biomedical applications of radioiodinated peptides
Oliveira, M. C., & Correia, J. D. G. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.014 · Cited by 26
Furan-Conjugated Tripeptides as Potent Antitumor Drugs
Ali, H., Jabeen, A., Maharjan, R., Nadeem-Ul-Haque, M., Aamra, H., Nazir, S., Khan, S., Olleik, H., Maresca, M., & Shaheen, F. (2020) · Biomolecules · doi:10.3390/biom10121684 · Cited by 26
The allosteric modulation of complement C5 by knob domain peptides
Macpherson, A., Laabei, M., Ahdash, Z., Graewert, M. A., Birtley, J. R., Schulze, M. E. D., Crennell, S. J., Robinson, S. A., Holmes, B., Oleinikovas, V., et al. (2021) · eLife · doi:10.7554/elife.63586 · Cited by 24
A Review on the Metabolism of 25 Peptide Drugs
Chia, C. S. B. (2021) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10177-0 · Cited by 26
Guardiola, S., Varese, M., Roig, X., Sánchez‐Navarro, M., García, J., & Giralt, E. (2021) · Chemical Science · doi:10.1039/d1sc01031j · Cited by 25
Bioactive Synthetic Peptides for Oral Tissues Regeneration
Bermúdez, M., Hoz, L., Montoya, G. A., Campos, M. N., Pérez‐Soria, A., Romo, E., Soto‐Barreras, U., Garnica-Palazuelos, J. C., Aguilar‐Medina, M., Ramos‐Payán, R., et al. (2021) · Frontiers in Materials · doi:10.3389/fmats.2021.655495 · Cited by 26
Lin, W., Yang, Y., Yang, L., An, F., Sun, L., Qin, Y. H., & Zhang, L. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c07983 · Cited by 26
Wang, D., Deng, B., Cheng, L., Li, J., Zhang, J., Zhang, X., Guo, X., Yan, T., Xin, Y., An, Y., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.09.001 · Cited by 25
HelixGAN a deep-learning methodology for conditional de novo design of α-helix structures
Xie, X., Valiente, P. A., & Kim, P. M. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad036 · Cited by 26
N‐Terminal‐Specific Dual Modification of Peptides through Copper‐Catalyzed [3+2] Cycloaddition
Machida, H., & Kanemoto, K. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202320012 · Cited by 27
Assessing the effectiveness of AS-48 in experimental mice models of Chagas’ disease
Martín‐Escolano, R., Cebrián, R., Maqueda, M., Romero, D., Rosales, M. J., Sánchez‐Moreno, M., & Marı́n, C. (2020) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkaa030 · Cited by 26
Singh, A. P., Guo, Y., Baldelli, A., & Singh, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092265 · Cited by 28
Lalani, N., Tivari, S. R., Jain, V. D., & Jadeja, Y. S. (2024) · Peptide Science · doi:10.1002/pep2.24343 · Cited by 25
Wei, Y., Wang, C., Jiang, B., Sun, C. C., & Middaugh, C. R. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01118 · Cited by 25
Schuhmacher, A., Shiro, T., Ryan, S. J., & Bode, J. W. (2020) · Chemical Science · doi:10.1039/d0sc01330g · Cited by 25
Feni, L., Jütten, L., Parente, S., Piarulli, U., Neundorf, I., & Díaz, D. (2020) · Chemical Communications · doi:10.1039/d0cc01490g · Cited by 25
An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
Wang, X., Wang, Y., Hu, J., & Xu, H. (2021) · Cancer Medicine · doi:10.1002/cam4.3768 · Cited by 25
Sadgrove, N. J., & Simmonds, M. S. J. (2021) · FASEB BioAdvances · doi:10.1096/fba.2021-00022 · Cited by 26
Imaging therapeutic peptide transport across intestinal barriers
Larsen, J. B., Taebnia, N., Dolatshahi‐Pirouz, A., Eriksen, A. Z., Hjørringgaard, C. U., Kristensen, K., Larsen, N. W., Larsen, N. B., Marie, R., Mündler, A.-K., et al. (2021) · RSC Chemical Biology · doi:10.1039/d1cb00024a · Cited by 26
Li, F., Wu, S., Chen, N., Zhu, J., Zhao, X., Zhang, P., Zeng, Y., & Liu, Z. (2021) · Toxins · doi:10.3390/toxins13120867 · Cited by 26
Pan-RAS inhibitors: Hitting multiple RAS isozymes with one stone
Coley, A. B., Ward, A., Keeton, A. B., Chen, X., Maxuitenko, Y. Y., Prakash, A., Li, F., Foote, J. B., Buchsbaum, D. J., & Piazza, G. A. (2022) · Advances in cancer research · doi:10.1016/bs.acr.2021.07.009 · Cited by 23
Oral delivery of glutathione: antioxidant function, barriers and strategies
Wei, T., Thakur, S. S., Liu, M., & Wen, J. (2022) · Acta Materia Medica · doi:10.15212/amm-2022-0005 · Cited by 27
Roles of Metal Ions in Foldamers and Other Conformationally Flexible Supramolecular Systems
Algar, J. L., Findlay, J. A., & Preston, D. (2022) · ACS Organic & Inorganic Au · doi:10.1021/acsorginorgau.2c00021 · Cited by 25
Efficient catalysis in dynamic nanomicelles of PS-750-M suspended in water
Kaur, G., Kaur, K., & Handa, S. (2022) · Current Opinion in Green and Sustainable Chemistry · doi:10.1016/j.cogsc.2022.100690 · Cited by 25
Baazaoui, N., & Iqbal, K. (2022) · Biomolecules · doi:10.3390/biom12101409 · Cited by 27
A composite peptide-supramolecular microneedle system for melanoma immunotherapy
Li, M., Wang, M., Li, L., Zhang, L., Ma, B., & Wang, W. (2022) · Nano Research · doi:10.1007/s12274-022-5236-z · Cited by 25
Real‐Time Observation of Diarylethene‐Based Photoswitches in a Cyclic Peptide Environment
Schweigert, C., Babii, O., Afonin, S., Schober, T., Leier, J., Michenfelder, N. C., Komarov, I. V., Ulrich, A. S., & Unterreiner, A. (2019) · ChemPhotoChem · doi:10.1002/cptc.201900005 · Cited by 25
Inchaurraga, L., Martínez‐López, A. L., Abdulkarim, M., Gumbleton, M., Quincoces, G., Peñuelas, I., Martín‐Arbella, N., & Irache, J. M. (2019) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2019.100006 · Cited by 25
Chakraborty, C., Bhattacharya, M., Mallick, B., Sharma, A. R., Lee, S., & Agoramoorthy, G. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1874348 · Cited by 25
Azadi, S., Yazdanpanah, M. A., Afshari, A., Alahdad, N., Chegeni, S., Angaji, A., Rezayat, S. M., & Tavakol, S. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241303818 · Cited by 24
Marciano, C. L., de Lima, J. V. F., Rosa, M. S. D. C., do Nascimento, R. A., Ferraz, A. D. O., da Silva, I. C., Chrysostomo-Massaro, T. N., da Rosa-Garzon, N. G., & Cabral, H. (2025) · Antibiotics · doi:10.3390/antibiotics14111115 · Cited by 32
The disruption of protein-protein interactions as a therapeutic strategy for prostate cancer
Matos, B., Howl, J., Jerónimo, C., & Fardilha, M. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105145 · Cited by 26
Matabaro, E., Kaspar, H., Dahlin, P., Bader, D. L. V., Murar, C. E., Staubli, F., Field, C. M., Bode, J. W., & Künzler, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83106-2 · Cited by 24
A Signaling View into the Inflammatory Tumor Microenvironment
Pereira, J., Jordan, P., & Matos, P. (2021) · Immuno · doi:10.3390/immuno1020007 · Cited by 24
MIF1 and MIF2 Myostatin Peptide Inhibitors as Potent Muscle Mass Regulators
Lee, E. J., Shaikh, S., Baig, M. H., Park, S., Lim, J. H., Ahmad, S. S., Ali, S. M., Ahmad, K., & Choi, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084222 · Cited by 24
Virtual Screening Expands the Non-Natural Amino Acid Palette for Peptide Optimization
Amarasinghe, K. N., Maria, L. D., Tyrchan, C., Eriksson, L. A., Sadowski, J., & Petrović, D. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00193 · Cited by 24
de Cena, G. L., Scavassa, B. V., & Conceição, K. (2022) · Pharmaceuticals · doi:10.3390/ph15091141 · Cited by 24
García‐Jacas, C. R., García‐González, L. A., Martínez-Rios, F., Tapia-Contreras, I. P., & Brizuela, C. A. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac428 · Cited by 25
Peptides in Dentistry: A Scoping Review
Hardan, L., Chedid, J. C. A., Bourgi, R., Cuevas‐Suárez, C. E., Łukomska−Szymańska, M., Tosco, V., Avila, A. J. M., Jabra, M., Salloum-Yared, F., Kharouf, N., et al. (2023) · Bioengineering · doi:10.3390/bioengineering10020214 · Cited by 25
Tonin, G., & Klen, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065446 · Cited by 24
Xu, Y.-D., Guo, X.-Y., Yan, D., Dang, X., Guo, L., Jia, T., & Wang, Q. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00310 · Cited by 25
Nature-inspired and medicinally relevant short peptides
Ciulla, M. G., Civera, M., Sattin, S., & Kumar, K. (2023) · Exploration of Drug Science · doi:10.37349/eds.2023.00011 · Cited by 26
Capillary electrophoresis in the analysis of therapeutic peptides—A review
Štefánik, O., Majerová, P., Kováč, A., Mikuš, P., & Piešťanský, J. (2023) · Electrophoresis · doi:10.1002/elps.202300141 · Cited by 25
Therapeutic implications of novel peptides targeting ER–mitochondria Ca2+-flux systems
Kerkhofs, M., Bultynck, G., Vervliet, T., & Monaco, G. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.03.020 · Cited by 25
Peptide/Receptor Co-evolution Explains the Lipolytic Function of the Neuropeptide TLQP-21
Sahu, B. S., Rodriguez, P., Nguyen, M. E., Han, R., Cero, C., Razzoli, M., Piaggi, P., Laskowski, L. J., Pavličev, M., Muglia, L. J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.101 · Cited by 24
Lafleur, M. A., Werner, J. A., Fort, M. M., Lobenhofer, E. K., Balázs, M., & Goyos, A. (2020) · Journal of Immunotoxicology · doi:10.1080/1547691x.2020.1757793 · Cited by 24
Retzl, B., Hellinger, R., Muratspahić, E., Pinto, M. E. F., Bolzani, V. S., & Gruber, C. W. (2020) · Journal of Natural Products · doi:10.1021/acs.jnatprod.0c00648 · Cited by 24
HelixDiff, a Score-Based Diffusion Model for Generating All-Atom α‑Helical Structures
Xie, X., Valiente, P. A., Kim, J., & Kim, P. M. (2024) · ACS Central Science · doi:10.1021/acscentsci.3c01488 · Cited by 21
Development of peptide therapeutics: A nonclinical safety assessment perspective
Mitra, M. S., DeMarco, S. J., Holub, B., Thiruneelakantapillai, L., & Thackaberry, E. A. (2020) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2020.104766 · Cited by 23
Hormone-like conopeptides – new tools for pharmaceutical design
Turner, A., Kaas, Q., & Craik, D. J. (2020) · RSC Medicinal Chemistry · doi:10.1039/d0md00173b · Cited by 24
Maraming, P., Daduang, J., & Kah, J. C. Y. (2021) · RSC Advances · doi:10.1039/d1ra05980g · Cited by 24
Zhang, X., Chai, Z., Lee Dobbins, A., Itano, M. S., Askew, C., Miao, Z., Niu, H., Samulski, R. J., & Li, C. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2021.121340 · Cited by 23
Gilad, A. A., Bar‐Shir, A., Bricco, A. R., Mohanta, Z., & McMahon, M. T. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4712 · Cited by 23
Park, J., Ngo, H. V., Jin, H., Lee, K. W., & Lee, B. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s356804 · Cited by 23
Mass Spectrometry Approaches Empowering Neuropeptide Discovery and Therapeutics
Anapindi, K. D. B., Romanova, E. V., Checco, J. W., & Sweedler, J. V. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000423 · Cited by 24
The industrial design, translation, and development strategies for long-acting peptide delivery
Yang, B., dos Santos, A. G., Puri, S., Bak, A., & Zhou, L. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2098276 · Cited by 26
Singh, S., Banavath, H. N., Godara, P., Naik, B., Srivastava, V., & Prusty, D. (2022) · 3 Biotech · doi:10.1007/s13205-022-03258-4 · Cited by 23
Chen, J., Jiang, F., & Wu, Y. (2022) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.2c00743 · Cited by 24
The Research Progress of Bioactive Peptides Derived from Traditional Natural Products in China
Zhang, Y., Liu, L., Zhang, M., Li, S., Wu, J., Sun, Q., Ma, S., & Cai, W. (2023) · Molecules · doi:10.3390/molecules28176421 · Cited by 24
Sun, M., Hu, H., Pang, W., & Zhou, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015447 · Cited by 23
Klaver, D., Posch, B., Geisler, A., Hermann, M., Reider, N., & Heufler, C. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.07.008 · Cited by 23
Piovesana, S., Cerrato, A., Antonelli, M., Benedetti, B., Capriotti, A. L., Cavaliere, C., Montone, C. M., & Laganà, A. (2019) · Journal of Chromatography A · doi:10.1016/j.chroma.2019.460699 · Cited by 23
Stimuli-Responsive Conformational Transformation of Peptides for Tunable Cytotoxicity
Lee, J., Oh, E., Lee, H., Kim, J.-W., Kim, H. G., Park, H. J., & Kim, C. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00730 · Cited by 23
Piešťanský, J., Baráth, P., Majerová, P., Galba, J., Mikuš, P., Kováčech, B., & Kováč, A. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113449 · Cited by 23
Protein–Peptide Binding Energetics under Crowded Conditions
Stadmiller, S. S., Aguilar, J. S., Parnham, S. R., & Pielak, G. J. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c05578 · Cited by 23
Small Molecule NF-κB Inhibitors as Immune Potentiators for Enhancement of Vaccine Adjuvants
Moser, B., Escalante-Buendia, Y., Steinhardt, R. C., Rosenberger, M. G., Cassaidy, B., Naorem, N., Chon, A. C., Nguyen, M. C., Tran, N., & Esser-Kahn, A. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.511513 · Cited by 23
Li, M., Akintelu, S. A., & Yao, B. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c01481 · Cited by 23
Afonso, A. L., Cavaleiro, C. T., Castanho, M. A. R. B., Neves, V., & Cavaco, M. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073117 · Cited by 26
Sanchís, I., Spinelli, R., Aschemacher, N. A., Húmpola, M. V., & Siano, Á. (2020) · Amino Acids · doi:10.1007/s00726-019-02815-1 · Cited by 22
Strategies to expand peptide functionality through hybridisation with a small molecule component
Wu, Y., Williams, J. P. C., Calder, E. D. D., & Walport, L. J. (2020) · RSC Chemical Biology · doi:10.1039/d0cb00167h · Cited by 23
Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction
Sgrignani, J., Cecchinato, V., Fassi, E. M. A., D’Agostino, G., Garofalo, M., Danelon, G., Pedotti, M., Simonelli, L., Varani, L., Grazioso, G., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00852 · Cited by 22
Khan, S. N., Shaheen, F., Aleem, U., Sheikh, S., Tamfu, A. N., Ashraf, S., Ul‐Haq, Z., Ullah, S., Wahab, A., Choudhary, M. I., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.106045 · Cited by 22
Mitochondrially-Targeted Therapeutic Strategies for Alzheimer’s Disease
Onyango, I. G., Bennett, J. P., & Stokin, G. B. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666211208125855 · Cited by 22
Borjas, T., Jacob, A., Yen, H.-T., Patel, V. M., Coppa, G. F., Aziz, M., & Wang, P. (2021) · Shock · doi:10.1097/shk.0000000000001894 · Cited by 23
Umpolung Ala B Reagents for the Synthesis of Non‐Proteogenic Amino Acids, Peptides and Proteins**
Zhu, F., Miller, E., Powell, W. C., Johnson, K. C., Beggs, A., Evenson, G. E., & Walczak, M. A. A. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202207153 · Cited by 23
Peptide‐based diagnostic and therapeutic agents: Where we are and where we are heading?
Khalily, M. P., & Soydan, M. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14180 · Cited by 22
Bibliometric Review of the Literature on Cone Snail Peptide Toxins from 2000 to 2022
Nguyen, L. T. T., Craik, D. J., & Kaas, Q. (2023) · Marine Drugs · doi:10.3390/md21030154 · Cited by 22
Hemajha, L., Singh, S., Biji, C. A., Balde, A., Benjakul, S., & Nazeer, R. A. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113130 · Cited by 23
Taricska, N., Horváth, D., Menyhárd, D. K., Ákontz‐Kiss, H., Noji, M., So, M., Goto, Y., Fujiwara, T., & Perczel, A. (2019) · Chemistry - A European Journal · doi:10.1002/chem.201903826 · Cited by 21
Neuropolybin: A new antiseizure peptide obtained from wasp venom
Silva, J. D. C. E., do Couto, L. L., Amaral, H. D. O., Gomes, F. M. M., Campos, G. A. A., Silva, L. P., & Mortari, M. R. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114119 · Cited by 22
Çağlar, A. F., Çakır, B., & Gülseren, İ. (2021) · European Food Research and Technology · doi:10.1007/s00217-021-03700-6 · Cited by 22
Peptide‐Based Inhibitors for SARS‐CoV‐2 and SARS‐CoV
Panchal, D., Kataria, J., Patel, K., Crowe, K. M., Pai, V., Azizogli, A., Kadian, N., Sanyal, S., Roy, A., Dodd‐o, J., et al. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100104 · Cited by 22
Specific inhibition of HIF activity: can peptides lead the way?
Mylonis, I., Chachami, G., & Simos, G. (2021) · Cancers · doi:10.3390/cancers13030410 · Cited by 21
Sabatino, G., D’Ercole, A., Pacini, L., Zini, M., Ribecai, A., Paio, A., Rovero, P., & Papini, A. M. (2021) · Organic Process Research & Development · doi:10.1021/acs.oprd.0c00490 · Cited by 21
ToxTeller: Predicting Peptide Toxicity Using Four Different Machine Learning Approaches
Wang, J.-H., & Sung, T. (2024) · ACS Omega · doi:10.1021/acsomega.4c04246 · Cited by 24
Peptide Bond Formation Between Unprotected Amino Acids: Convergent Synthesis of Oligopeptides
Hattori, T., & Yamamoto, H. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c08049 · Cited by 22
NMR Spectroscopy in the Conformational Analysis of Peptides: An Overview
Vincenzi, M., Mercurio, F. A., & Leone, M. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200702131032 · Cited by 21
Peptide Modification via N-Terminal-Residue-Directed γ-C(sp3)–H Arylation
Hou, Z.-L., Yuan, F., & Yao, B. (2020) · Organic Letters · doi:10.1021/acs.orglett.0c03279 · Cited by 21
Zitterbart, R., Berger, N., Reimann, O., Noble, G. T., Lüdtke, S., Sarma, D., & Seitz, O. (2021) · Chemical Science · doi:10.1039/d0sc06285e · Cited by 21
Casagrande, N., Borghese, C., Gabbatore, L., Morbiato, L., Zotti, M. D., & Aldinucci, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168362 · Cited by 21
β-Hairpin Peptide Mimics Decrease Human Islet Amyloid Polypeptide (hIAPP) Aggregation
Lesma, J., Bizet, F., Berardet, C., Tonali, N., Pellegrino, S., Taverna, M., Khemtémourian, L., Soulier, J. L., van Heijenoort, C., Halgand, F., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.729001 · Cited by 20
Lieser, R. M., Li, Q., Chen, W., & Sullivan, M. O. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00788 · Cited by 22
Characterization of endogenous peptides from Dromedary and Bactrian camel milk
Zhang, L., Han, B., Luo, B., Ni, Y., Bansal, N., & Zhou, P. (2022) · European Food Research and Technology · doi:10.1007/s00217-021-03952-2 · Cited by 22
Behzadipour, Y., & Hemmati, S. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-021-10357-y · Cited by 21
Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers
Calatayud, D. G., Neophytou, S., Nicodemou, E., Giuffrida, S. G., Ge, H., & Pascu, S. I. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.830133 · Cited by 21
Escherichia coli - Old and New Insights
Erjavec, M. S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.95203 · Cited by 23
Delivery of Small Molecules by Syndiotactic Peptides for Breast Cancer Therapy
Jerath, G., Darvin, P., Christian, Y., Trivedi, V., Kumar, T. R. S., & Ramakrishnan, V. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00238 · Cited by 21
Peptidomimetics and Their Applications for Opioid Peptide Drug Discovery
Lee, Y. S. (2022) · Biomolecules · doi:10.3390/biom12091241 · Cited by 21
Peptide-Based Therapeutics in Cancer Therapy
Jalil, A. T., Abdulhadi, M. A., Al-Ameer, L. R., Taher, W. M., Abdulameer, S. J., Abosaooda, M., & Fadhil, A. A. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00873-1 · Cited by 21
Metadata
- Authors
- Lau, J. L., & Dunn, M. K.
- Affiliations
- Ferring Research Institute (United States) (US)
- Corresponding author
- Dunn, Michael K.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2018-06
- Volume
- 26
- Issue
- 10
- Pages
- 2700-2707
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2724823461
- Cited by
- 1,879
- References
- 44
- Citations by year
- 2026: 146 · 2025: 179 · 2024: 205 · 2023: 236 · 2022: 299 · 2021: 275 · 2020: 278 · 2019: 194 · 2018: 59
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Bioorganic & Medicinal Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- peptide therapeutics, peptide drug discovery, clinical development, insulin, therapeutic areas
- MeSH terms
- Animals, Drug Evaluation, Humans, Peptides, Drug Approval, Drug Discovery, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review